The Impact of LEP rs7799039 Polymorphism and Obesity on the Severity of Coronavirus Disease-19
- PMID: 36852180
- PMCID: PMC9961580
- DOI: 10.2147/DMSO.S391869
The Impact of LEP rs7799039 Polymorphism and Obesity on the Severity of Coronavirus Disease-19
Abstract
Background and aims: SARS-CoV-2 infection has been recorded in 230 countries to date. Obesity has a negative impact on one's quality of life and is one of the main causes of mortality globally. Obesity affects the immune system, making the host more susceptible to infectious infections. Also, obesity commonly provokes the severity of respiratory diseases so the correlation of LEP rs7799039 Polymorphism in corpulent patients with COVID-19 infection was clearly investigated in the current study.
Methods: A total of 232 patients were recruited, 116 patients were obese with COVID-19 infection, and 116 patients were non obese COVID-19. Fasting blood glucose test (FBG), hemoglobin A1C (HbA1C), complete blood count (CBC), international normalized ratio (INR), urea, alanine transaminase (ALT), aspartate aminotransferase (AST), D dimer and C-reactive protein (CRP) were estimated. C.T. scan was performed for each patient, and C.T. severity score was calculated. Genotyping for the leptin rs7799039 SNPs was performed by TaqMan® (Applied Biosystems Step One TM Real-time PCR).
Results: Regarding LEP polymorphism, all individuals of non-obese groups significantly had the homozygous allele GG (100%), whereas only 56% of obese groups had GG alleles (P = 0.001). The severity scores significantly (P = 0.001) varied regarding LEP polymorphism regarding Rs7799039, where the largest proportion of those with Grade IV had the homozygous allele AA (57.1%).
Conclusion: There was a correlation between the leptin gene allelic discrimination and COVID-19 CT brutality in obese patients. The A allele was considered a risk factor for severity in COVID-19 patients while the G allele contributes to decreasing that risk.
Keywords: COVID-19; gene polymorphism; immunity; leptin; obesity.
© 2023 Mohamed et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Polymorphisms in the leptin (rs7799039) gene are associated with an increased risk of excessive gestational weight gain but not with leptin concentration during pregnancy.Nutr Res. 2017 Nov;47:53-62. doi: 10.1016/j.nutres.2017.09.003. Epub 2017 Sep 15. Nutr Res. 2017. PMID: 29241578
-
Association study of rs7799039, rs1137101 and rs8192678 gene variants with disease susceptibility/severity and corresponding LEP, LEPR and PGC1A gene expression in multiple sclerosis.Gene. 2021 Mar 30;774:145422. doi: 10.1016/j.gene.2021.145422. Epub 2021 Jan 12. Gene. 2021. PMID: 33450350
-
Modification effect of sex and obesity on the correlation of LEP polymorphisms with leptin levels in Taiwanese obese women.Mol Genet Genomic Med. 2020 Mar;8(3):e1113. doi: 10.1002/mgg3.1113. Epub 2020 Jan 8. Mol Genet Genomic Med. 2020. PMID: 31914480 Free PMC article.
-
Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Aug 30;102:109952. doi: 10.1016/j.pnpbp.2020.109952. Epub 2020 Apr 23. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32335267
-
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.J Transl Autoimmun. 2021;4:100083. doi: 10.1016/j.jtauto.2021.100083. Epub 2021 Jan 6. J Transl Autoimmun. 2021. PMID: 33521616 Free PMC article. Review.
Cited by
-
Genetic variant panel allows predicting both obesity risk, and efficacy of procedures and diet in weight loss.Front Nutr. 2023 Nov 16;10:1274662. doi: 10.3389/fnut.2023.1274662. eCollection 2023. Front Nutr. 2023. PMID: 38035352 Free PMC article.
-
The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients.BMC Cancer. 2024 Aug 1;24(1):937. doi: 10.1186/s12885-024-12716-6. BMC Cancer. 2024. PMID: 39090596 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous